Skip to main content

Month: August 2020

Addex Therapeutics to Release Half-Year 2020 Financial Results and Host Conference Call on August 12, 2020

Geneva, Switzerland, August 10, 2020 – Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, will discuss its half-year 2020 financial results, provide a business update and review its pipeline during a teleconference and webcast for investors, analysts and the media on Wednesday, August 12 at 16:00 CEST (14:00 GMT/10:00 ET).Title:                    Addex Half-Year 2020 Financial Results Conference CallDate:                   August 12, 2020Time:                  16:00 CEST (14:00 GMT/10:00 ET)Joining the Conference Call:In the 10 minutes prior to the call start time, call the appropriate participant dial-in number.Dial-in numbers:Switzerland:         +41 44 58 06 522United States:      +1 877 4230830United Kingdom:  +44 203 0092470Link for other countriesParticipation...

Continue reading

WISeKey Completes $5 Million Private Placement with Crede Capital Group

Zug, Switzerland, August 10, 2020 – WISeKey International Holding Ltd (“WISeKey” or “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, announced today that it has entered into a Convertible Loan Agreement with a fund managed by Crede Capital Group, LLC (“Crede”).“WISeKey is entering into an exciting phase of development. Digital transformation remains a key priority through the development of disruptive technologies and harnessing of its power to overcome key challenges of a complex world and unlock new growth opportunities.  This convertible loan facility will be used to finance the expansion of existing IoT operations in US, new opportunities and possible M&A activities, aiming to expand the technology portfolio of the company,” said Carlos Moreira, Founder and CEO of WISeKey.Under...

Continue reading

VGP NV: Announces Conference Call to Review First Half 2020 Financial Results

10 August 2020, Antwerp (Berchem), Belgium: VGP NV (‘VGP’ or ‘the Group’), a leading European provider of high-quality logistics and semi-industrial real estate, announces the details for the conference call to review the financial results for the half year ended 30 June 2020: Monday, 24 August 2020 at 10.30 a.m. (CET)Dial-in details:Belgium: 0800 58228 (toll free) / +32 (0)2 404 0659UK: 0800 358 6377 (toll free) / +44 (0)330 336 9105US: 866-548-4713 (toll free) / +1 323-794-2093Confirmation Code: 3420218Please join the event conference 5-10 minutes prior to the start time. The financial results are scheduled to be released at approximately 7:00 a.m. (CET) on the date noted above, and presentation slides will be made available on www.vgpparks.eu under Investors, Publications, Financial & Operating Results.CONTACT DETAILS FOR INVESTORS...

Continue reading

VGP NV: Kondigt Teleconferentie aan voor Bespreking van de Resultaten over Eerste Halfjaar 2020

10 augustus 2020, Berchem (Antwerpen), België: VGP NV (‘VGP’ of ‘de Groep’), een toonaangevende pan-Europese ontwikkelaar, manager en eigenaar van kwalitatief hoogstaand logistiek en semi-industrieel vastgoed, kondigt de details aan voor een telefoonconferentie ter bespreking van de resultaten over het halfjaar eindigend op 30 juni 2020: maandag, 24 augustus 2020, om 10.30 a.m. (CET)Inbelgegevens:België: 0800 58228 (gratis) / +32 (0)2 404 0659VK: 0800 358 6377 (gratis) / +44 (0)330 336 9105VS: 866-548-4713 (gratis) / +1 323-794-2093Bevestigingscode: 3420218Vriendelijk verzoek reeds 5-10 minuten voor de geplande starttijd van de telefoonconferentie in te bellen. De financiële resultaten worden, volgens planning, om 7 uur a.m. (CET) op bovenstaande dag gepubliceerd en een presentatie zal beschikbaar worden gesteld op www.vgpparks.eu/nl/...

Continue reading

Banque Profil de Gestion SA : Rapport semestriel 2020

Communiqué de presseBanque Profil de Gestion SA :Rapport semestriel 2020Genève, le 10 août 2020 – La Banque Profil de Gestion SA (SIX Swiss Exchange : BPDG) annonce que son rapport semestriel 2020 (composé du bilan, du compte de résultat, du tableau de flux de trésorerie et d’un état des capitaux propres) est désormais en ligne sur son site Internet dans la section « Relations investisseurs / Publications » et peut être téléchargé au moyen du lien suivant :https://www.bpdg.ch/fr/relations-investisseurs#publicationsLa Banque Profil de Gestion SA (SIX Swiss Exchange : BPDG) est une banque suisse établie à Genève. Fondée sur des valeurs d’éthique, de détermination et de culture du service, la Banque Profil de Gestion SA est spécialisée dans la gestion de patrimoine. La Banque est dirigée par Mme Silvana Cavanna, Présidente de la Direction...

Continue reading

Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis

Etrolizumab met its primary endpoint of inducing remission versus placebo for people with ulcerative colitis in only two of three studiesEtrolizumab failed to meet its primary endpoint versus placebo as maintenance therapy in people with ulcerative colitisAnalyses of these data are ongoing to better understand the resultsPivotal phase III study of etrolizumab in Crohn’s disease is ongoingRoche is studying additional investigational medicines in inflammatory bowel diseasesBasel, 10 August 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced topline results from its phase III study programme evaluating the investigational medicine etrolizumab in people with moderately to severely active ulcerative colitis. Mixed results were seen in studies evaluating etrolizumab as an induction therapy, and both studies evaluating etrolizumab...

Continue reading

SEB Boprisindikatorn, Fortsatt kraftig återhämtning i boprisförväntningarna

Fortsatt kraftig återhämtning i boprisförväntningarnaSEB:s Boprisindikator fortsätter att återhämta sig och ökar med 16 enheter i augusti, från 24 till 40. På regional nivå är det små skillnader och indikatorn ligger i de sex regionerna mellan 27 och 37. Hushållens förväntningar på reporäntans nivå minskar något och ligger i augusti på 0,41 procent. Andelen som planerar att binda sina rörliga lån ligger på 3 procent, vilket är en nedgång med 2 procentenheter jämfört med föregående månad.Andelen hushåll som tror på stigande priser ökar med 10 procentenheter jämfört med förra månaden och ligger nu på 52 procent. Andelen hushåll som tror på sjunkande priser det kommande året uppgår nu till 12 procent, att jämföra med 18 procent föregående månad. Andelen som tror på oförändrade priser minskar från 30 till 27 procent. Boprisindikatorn är skillnaden...

Continue reading

Unigold Intersects 30.0 meters averaging 9.02 g/t Au at Candelones Extension Deposit in the Dominican Republic

Unigold reports the longest, highest grade intersection drilled to date at Neita:   30 metres averaging 9.02 g/t gold, 5.1 g/t silver, 0.63% copperIntercept is contained within a larger interval of 104.1 metres grading 3.14 g/t gold, 2.1 g/t silver, 0.27% Cu.Gold grades are consistent throughout the interval, ranging from 4 g/t to 19 g/t goldGeological interpretation that system is strengthening to depth is reinforced by this resultSystem is open to depth: deepest intercept is 350m below surface15,000 m drill program expected to commence within the next 10 daysTORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Unigold Inc. (“Unigold” or the “Company”) (TSX-V:UGD) is pleased to announce additional results from its completed Phase 1 drill program at the Candelones Extension deposit, part of the Company’s 100% owned Neita Concession in the...

Continue reading

TopAlliance Appoints Patricia Keegan, M.D., as Chief Medical Officer

ROCKVILLE, Md., Aug. 09, 2020 (GLOBE NEWSWIRE) — TopAlliance Biosciences, a wholly own subsidiary of Shanghai Junshi Biosciences (HKEX: 1877; SSE: 688180) today announced the appointment of Dr. Patricia Keegan, as Chief Medical Officer and Senior Vice President. Dr. Keegan brings over three decades of experience as a board-certified medical oncologist, clinical researcher, and regulatory authority at FDA.“We are very glad to welcome Patricia on board,” said Ning Li, M.D., Ph.D., Chief Executive Officer of Shanghai Junshi Biosciences. “Dr. Keegan is an accomplished clinician and regulator with an impressive track record of advancing, reviewing and approving oncology products in the past 30 years. She will contribute significantly to the growth of the company as we thrive to expand Junshi/TopAlliance’s pipeline and advance drug programs...

Continue reading

Par Pacific Holdings Reports Second Quarter 2020 Results

HOUSTON, Aug. 09, 2020 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific” or the “Company”) today reported its financial results for the quarter ended June 30, 2020.Par Pacific reported a net loss of $40.6 million, or $(0.76) per diluted share, for the quarter ended June 30, 2020, compared to net income of $28.2 million, or $0.56 per diluted share, for the same quarter in 2019. Second quarter 2020 Adjusted Net Loss was $90.8 million, compared to Adjusted Net Income of $22.4 million in the second quarter of 2019. Second quarter 2020 Adjusted EBITDA was $(50.3) million, compared to $68.5 million in the second quarter of 2019. A reconciliation of reported non-GAAP financial measures to their most directly comparable GAAP financial measures can be found in the tables accompanying this news release.“We are pleased with the record...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.